NB: Before reading the Zynerba Pharmaceuticals, Inc. analysis below, we’d like to bring your attention to some excellent services for trading stocks like this:
Beat The Market Analyzer: https://logistics-business-review.com/recommended-tool-for-ZYNE-investors (this is a fantastic tool – use this to analyze Zynerba Pharmaceuticals, Inc. in much more depth)
MM Publishing: https://logistics-business-review.com/mmpublishing-for-ZYNE-investors
Trading Code: https://logistics-business-review.com/tradingcode-for-ZYNE-investors
Trader HR: https://logistics-business-review.com/traderHR-for-ZYNE-investors
REPORTING FOR 2019-07-15 | LOGISTICS-BUSINESS-REVIEW.COM: We have conducted a deep analysis of how Zynerba Pharmaceuticals, Inc. ($ZYNE) has been trading over the last 2 weeks and the past day especially. On its latest session, Zynerba Pharmaceuticals, Inc. ($ZYNE) opened at 14.39, reaching a high of 14.48 and a low of 13.6 before closing at a price of 13.64. There was a total volume of 1243712.
VOLUME INDICATORS: We saw an accumulation-distribution index of 307.94033, an on-balance volume of -14.4, chaikin money flow of 18.55556 and a force index of 0.4158. There was an ease of movement rating of -0.00163, a volume-price trend of 5.74821 and a negative volume index of 1000.0.
VOLATILITY: We noted an average true range of 0.45315, bolinger bands of 13.60914, an upper bollinger band of 13.58086, lower bollinger band of 13.6, a bollinger high band indicator of 1.0, bollinger low band indicator of 1.0, a central keltner channel of 14.15667, high band keltner channel of 14.06667, low band keltner channel of 14.24667, a high band keltner channel indicator of 1.0 and a low band keltner channel indicator of 1.0. There was a donchian channel high band of 13.6, a donchian channel low band of 13.6, a donchian channel high band indicator of 1.0, and a donchian channel low band indicator of 1.0.
TREND: We calculated a Moving Average Convergence Divergence (MACD) of -0.00022, a MACD signal of -0.00012, a MACD difference of -0.0001, a fast Exponential Moving Average (EMA) indicator of 13.6, a slow Exponential Moving Average (EMA) indicator of 13.6, an Average Directional Movement Index (ADX) of unknown, an ADX positive of 20.0, an ADX negative of 20.0, a positive Vortex Indicator (VI) of 1.0, a negative VI of 1.0, a trend vortex difference of 0.09786, a trix of 20.23959, a Mass Index (MI) of 1.0, a Commodity Channel Index (CCI) of 66.66667, a Detrended Price Oscillator (DPO) of -4.04097, a KST Oscillator (KST) of 422.73835 and a KST Oscillator (KST Signal) of 422.73835 (leaving a KST difference of -0.26153). We also found an Ichimoku rating of 14.435, an Ichimoku B rating of 14.435, a Ichimoku visual trend A of 11.03146, an Ichimoku visual trend B of 12.33623, an Aroon Indicator (AI) up of 4.0 and an AI indicator down of 4.0. That left a difference of -4.0.
MOMENTUM: We found a Relative Strength Index (RSI) of 50.0, a Money Flow Index (MFI) of 100.0, a True Strength Index (TSI) of 100.0, an ultimate oscillator of 83.64717, a stochastic oscillator of 977.77778, a stochastic oscillator signal of 977.77778, a Williams %R rating of 877.77778 and an awesome oscillator of 0.09845.
RETURNS: There was a daily return of 42.27384, a daily log return of -0.07356 and a cumulative return of -0.07353.
What the heck does all of this mean? If you are new to technical analysis, the above may be gibberish to you, and that’s OK (though we do advise learning these things). The bottom line is that AS OF 2019-07-15 (if you are reading this later, the analysis will be out of date), here is what our deep analysis of technical indicators are telling us for Zynerba Pharmaceuticals, Inc. ($ZYNE)…
For a more complete analysis, run all of this through the BTMA software. Also, to stay up to date with what is happening on Zynerba Pharmaceuticals, Inc., we strongly advise Zynerba Pharmaceuticals, Inc. investors to subscribe to MarketBeat.com’s daily email newsletter for updates, news and analyst ratings on stocks like Zynerba Pharmaceuticals, Inc. – without this you are trading blind:
We will of course continue to cover the news and price action of Zynerba Pharmaceuticals, Inc., but it’s easiest for you to just subscribe to MarketBeat’s newsletter above so you don’t miss anything.
DISCLAIMER: We are not registered investment advisers and the above analysis should be taken at face value only. We strongly advise against buying or selling Zynerba Pharmaceuticals, Inc. ($ZYNE) based solely on our analysis above, and are not responsible for any losses that you may incur if you choose make any investment decisions based on the above.